Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection

NCT01829971 is registered in ClinicalTrials.gov with Mirna Therapeutics, Inc. as lead sponsor.

NCT NCT01829971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01829971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
Lead sponsor
Mirna Therapeutics, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
April 30, 2013
Completion date
May 31, 2017
Enrollment
155 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, melanoma, multiple myeloma, nsclc, primary liver cancer, renal cell carcinoma, sclc